Reference | 1: La J, Latham CF, Tinetti RN, Johnson A, Tyssen D, Huber KD, Sluis-Cremer N,
Simpson JS, Headey SJ, Chalmers DK, Tachedjian G. Identification of
mechanistically distinct inhibitors of HIV-1 reverse transcriptase through
fragment screening. Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):6979-84. doi:
10.1073/pnas.1423900112. Epub 2015 May 18. PubMed PMID: 26038551; PubMed Central
PMCID: PMC4460473.
2: Bellucci L, Angeli L, Tafi A, Radi M, Botta M. Unconventional plasticity of
HIV-1 reverse transcriptase: how inhibitors could open a connection "gate"
between allosteric and catalytic sites. J Chem Inf Model. 2013 Dec
23;53(12):3117-22. doi: 10.1021/ci400414s. Epub 2013 Nov 25. PubMed PMID:
24256065.
3: Freisz S, Bec G, Radi M, Wolff P, Crespan E, Angeli L, Dumas P, Maga G, Botta
M, Ennifar E. Crystal structure of HIV-1 reverse transcriptase bound to a
non-nucleoside inhibitor with a novel mechanism of action. Angew Chem Int Ed
Engl. 2010 Mar 1;49(10):1805-8. doi: 10.1002/anie.200905651. PubMed PMID:
20135654.
4: Guillon G, Pena A, Murat B, Derick S, Trueba M, Ventura MA, Szeto HH, Wo N,
Stoev S, Cheng LL, Manning M. Position 4 analogues of [deamino-Cys(1)] arginine
vasopressin exhibit striking species differences for human and rat V(2)/V(1b)
receptor selectivity. J Pept Sci. 2006 Mar;12(3):190-8. PubMed PMID: 16130178.
5: Lammek B, Bankowski K, Misicka A, Manning M, Seto J, Sawyer WH.
2-O-alkyltyrosine derivatives of 1-deamino-arginine-vasopressin: highly specific
and potent antidiuretic agonists. J Med Chem. 1989 Jan;32(1):244-7. PubMed PMID:
2909737.
|